Covestor LTD Maravai Lifesciences Holdings, Inc. Transaction History

Covestor LTD

$160 Million
Q4 2024

A detailed history of Covestor LTD transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Covestor LTD holds 1,022 shares of MRVI stock, worth $4,169. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,022

Previous 1,021 0.1%

Holding current value

$4,169

Previous $8,000 25.0%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$4.42 - $8.5 $4 - $8	1 Added 0.1%	1,022 $6,000
Q3 2024 Nov 01, 2024	BUY	$6.84 - $9.73 $6 - $9	1 Added 0.1%	1,021 $8,000
Q2 2024 Aug 09, 2024	BUY	$6.87 - $11.34 $20 - $34	3 Added 0.29%	1,020 $7,000
Q1 2024 May 10, 2024	SELL	$5.11 - $8.76 $245 - $420	-48 Reduced 4.51%	1,017 $9,000
Q4 2023 Feb 09, 2024	BUY	$4.7 - $9.87 $2,650 - $5,566	564 Added 112.57%	1,065 $7,000
Q3 2023 Nov 13, 2023	SELL	$9.14 - $12.85 $5,356 - $7,530	-586 Reduced 53.91%	501 $5,000
Q2 2023 Aug 11, 2023	BUY	$12.09 - $15.0 $7,519 - $9,330	622 Added 133.76%	1,087 $14,000
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $12 - $16	1 Added 0.22%	465 $7,000
Q4 2022 Feb 13, 2023	BUY	$12.5 - $24.78 $2,425 - $4,807	194 Added 71.85%	464 $6,000
Q3 2022 Nov 14, 2022	SELL	$20.6 - $30.37 $72,573 - $106,993	-3,523 Reduced 92.88%	270 $7,000
Q2 2022 Aug 10, 2022	BUY	$26.05 - $37.48 $86,459 - $124,396	3,319 Added 700.21%	3,793 $108,000
Q1 2022 May 13, 2022	BUY	$24.46 - $40.92 $2,030 - $3,396	83 Added 21.23%	474 $17,000
Q4 2021 Feb 10, 2022	BUY	$35.0 - $45.94 $13,685 - $17,962	391 New	391 $16,000

Others Institutions Holding MRVI

# of Institutions

203

Shares Held

138M

Call Options Held

271K

Put Options Held

37.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $537M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account